Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Using skin stem cells and certain molecules might lead to scar-free skin healing.

The oral contraceptive improved hair and skin quality in women.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Belimumab effectively controls SLE disease activity and reduces steroid use.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Stem cell research and regenerative medicine have made significant advancements in treating various diseases and conditions.

MSC-protein helps regenerate gum tissue and bone.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Some drugs can cause serious side effects like heart issues and nervous system problems, but certain drugs for Parkinson's and overactive bladder may be safer, though they still have some common side effects.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Finasteride 1 mg/day for five years effectively improves hair growth and slows hair loss in men with male pattern baldness, and is safe for long-term use.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Skin reactions from cancer treatments might predict how well the treatments work.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.